There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open-
High-
Low-
Prev. Close-
Avg. Traded Price-
Volume-
MARKET DEPTH
Total bid0.00
Total ask0.00
Orders
Qty
Bid
Ask
Qty
Orders
HIGH/LOW
1d
1w
1m
3m
52w
LOW/HIGH
₹3,175.00a day ago
₹3,259.00a day ago
LOWER/UPPER CIRCUITS
₹2,933.00
₹3,584.60
Torrent Pharmaceuticals Ltd Stock performance
KEY OBSERVATIONS
positive
negative
neutral
Annual Revenue,rose 6.98%, in the last year to ₹11,539 Cr. Its sector's average revenue growth for the last fiscal year was 10.81%.
Annual Net Profit,rose 15.37% in the last year to ₹1,911 Cr. Its sector's average net profit growth for the last fiscal year was 38.61%.
Return on Equity(ROE),for the last financial year was 25.17%, more than 20% in the last financial year, indicating an efficient use of shareholder's capital to generate profit.
View more
LONG-TERM PRICE ANALYSIS
Stock return5Y CAGR : 21.68%
Net profit growth 5Y CAGR : 30.59%
STOCK RETURNS
Versus Nifty 50
1 w
+2.04%
vs
+1.58%
1 mth
-0.99%
vs
+0.87%
3 mth
+3.53%
vs
+11.89%
6 mth
-3.67%
vs
+2.41%
1 yr
+10.79%
vs
+7.8%
3 yr
+123.85%
vs
+55.18%
5 yr
+157.91%
vs
+152.1%
Torrent Pharmaceuticals Ltd Top mutual funds holding
Torrent Pharmaceuticals Limited has established itself as a major player in the Indian Pharma arena. The company has well segregated marketing divisions, strategically structured on specific therapeutic areas and enjoys dominance in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC). With Unichem's domestic business acquisition, Torrent has entered the list of top pharma firms in the Indian Pharma Market (IPM) and is ranked No 8 in the IPM.
Grow your wealth with more research recommendations